enGene Holdings Inc.

NASDAQ:ENGN

Biotechnology

Healthcare
$1.85 -1.15%

-$0.02 today

Market cap
$123.98M
Beta
-0.29
P/E (TTM)
-1.8
EPS (TTM)
-$0.95
52W Low $1.40High $12.25

Volume 2.81M

Average 1.58M

ENGN Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

enGene Holdings Inc.NASDAQ: ENGN

Total Assets · Q2 FY2026 · quarter ended Apr 2026

Total assets rises 15.3% from a year ago

Total assets stood at $307.52M at the end of Q2 FY2026, up 15.3% from a year earlier and down 8.8% from the prior quarter. Over 3 fiscal years it compounded at +18.8% a year.

Context

  • Total assets increased in 1 of the last 3 fiscal years.

What to watch

Whether total assets keeps rising in the next quarterly balance sheet after a +15.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterApr 2026
$307.52M-8.8% QoQ
Last fiscal yearOct 2025
$221.47M-28.8% YoY
Year agoApr 2025
$266.65M+15.3% since
Total Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.3%——
1 year-28.8%——
3-year CAGR+18.8%——
5-year CAGR——
10-year CAGR——

Total Assets history

USD · from the balance sheet

Latest · FY2025
221.47M USD
Year-over-year change
-28.8%
4-year CAGR
+13.9%

Total Assets vs competitors

How ENGN compares with its peers on the latest reported figures

  • Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +15.3% is the 5th highest of 11, against a peer median of -5.4%.
  • Over three fiscal years its annual growth of +18.8% compares with a peer median of +5.9%.
ENGN Competitors
Total Assets for ENGN and competitors
Company Period Latest balance YoY 3-year CAGR
AMRNAmarin Corporation plcMar 2026$645.76M USD-1.5%-8.9%
ALTAltimmune, Inc.Mar 2026$335.63M USD+113.4%+10.6%
ENGNenGene Holdings Inc.Apr 2026$307.52M USD+15.3%+18.8%
CLLSCellectis S.A.Mar 2026$289.19M USD-20.6%+7.5%
ANROAlto Neuroscience, Inc.Mar 2026$276.26M USD+60.7%+53.7%
DBVTDBV Technologies S.A.Mar 2026$266.4M USD+426.9%-1.8%
ANNXAnnexon, Inc.Mar 2026$262.89M USD-13.2%-0.9%
LRMRLarimar Therapeutics, Inc.Mar 2026$208.51M USD+22.5%+4.9%
KRROKorro Bio, Inc.Mar 2026$183.62M USD-9.2%+15.5%
ACIUAC Immune S.A.Mar 2026CHF 137.42M CHF-34.9%-6.0%
SLNSilence Therapeutics plcMar 2026$115.12M USD-37.9%+6.9%
Peer median (excluding ENGN) —-5.4%+5.9%

Competitors are the stored peer set for ENGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Cash & Equivalents1.07M314.15K81.52M173M50.15M
Short-term Investments0076K65.4M143.66M
Net Receivables002.34M1.03M2.23M
Inventory00000
Other Current Assets001.5M7.93M5.35M
Total Current Assets1.57M511.8K85.44M247.36M201.39M
Property, Plant & Equipment (Net)00589K2.91M10.19M
Goodwill00000
Intangible Assets00000
Long-term Investments129.67M131.53M70K59.53M8.52M
Tax Assets00000
Other Non-current Assets209.05K939K860K1.37M1.36M
Total Non-current Assets129.88M131.53M1.52M63.81M20.08M
Total Assets131.45M132.04M86.96M311.17M221.47M
Account Payables001.16M1.41M6.69M
Short-term Debt1.05M1.27M562K1.12M10.02M
Tax Payables022K39K00
Deferred Revenue00000
Other Current Liabilities327.45K893.51K2.69M8.65M11.2M
Total Current Liabilities327.45K893.51K5.26M14.66M31.98M
Long-term Debt009.22M22.47M15.32M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)3.73M0000
Other Non-current Liabilities03.73M000
Total Non-current Liabilities3.73M3.73M9.22M23.9M21.78M
Total Liabilities4.05M4.62M14.47M38.56M53.76M
Common Stock129.67M131.53M259.37M509.81M513.28M
Retained Earnings(2.28M)(4.11M)(199.59M)(254.73M)(372.03M)
Accumulated OCI00(1.02M)(1.42M)(888K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity127.39M127.42M72.49M272.61M167.71M
Total Debt4.16M32.11M9.78M25.02M31.8M
Net Debt(1.07M)(314.15K)(71.74M)(147.98M)(18.36M)

enGene Holdings Inc.

NASDAQ:ENGN

Intrinsic Alpha fair value

Locked

Current Price

$1.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.